Evaluation of bone marrow reticulin in patients with chronic immune thrombocytopenia treated with eltrombopag: Data from the EXTEND study
Authors:
- 22 June 2015
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 90 (7) , 598-601
Abstract
Thrombopoietin receptor agonists, which raise platelet counts in patients with chronic immune thrombocytopenia, may be associated with increases in bone marrow (BM) reticulin. Patients with chronic immune thrombocytopenia participating in the Eltrombopag Extended Dosing (EXTEND) study underwent BM biopsies to identify clinically relevant BM fibrosis‐related increases. Specimens were centrally reviewed by 2 hematopathologists. Two hundred thirty‐two biopsy specimens were collected from 117 patients treated for ≤5.5 years. Moderate to marked reticulin fibrosis was found in 2 patients. After withdrawing from the study, the biopsy of 1 patient reverted to normal. There were no other pathologic changes identified among on‐treatment specimens, and no pattern of abnormal reticulin deposition associated with eltrombopag treatment was evident. Am. J. Hematol. 90:598–601, 2015.Keywords
This publication has 13 references indexed in Scilit:
- Bone marrow fibrosis in 66 patients with immune thrombocytopenia treated with thrombopoietin-receptor agonists: a single-center, long-term follow-upHaematologica, 2014
- Evaluation Of The Effects Of Long-Term Treatment With Eltrombopag On Bone Marrow In Patients With Chronic Immune Thrombocytopenia (ITP) — Data From The EXTEND StudyBlood, 2013
- Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND studyBlood, 2013
- Thrombopoietin receptor agonist therapy in primary immune thrombocytopenia is associated with bone marrow hypercellularity and mild reticulin fibrosis but not other stromal abnormalitiesLaboratory Investigation, 2012
- Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agentsBritish Journal of Haematology, 2011
- Bone marrow reticulin and collagen content in patients with adult chronic immune thrombocytopenic purpura: A Danish nationwide studyAmerican Journal of Hematology, 2010
- Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostimBlood, 2009
- Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITPBlood, 2009
- Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialThe Lancet, 2008
- Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonistExperimental Hematology, 2005